MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.
Gloria BertoliClaudia CavaCecilia DiceglieCristina MartelliGiampiero RizzoFrancesca PiccottiLuisa OttobriniIsabella CastiglioniPublished in: Breast cancer research and treatment (2016)
Our results suggest a potential role of Hsa-miR-567 as a novel prognostic biomarker for BC and as regulator of KPNA4.